Ameritas Investment Partners’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,428
| Closed | -$349K | – | 3210 |
|
|
2025
Q2 | $349K | Buy |
7,428
+481
| +7% | +$21.4K | 0.01% | 989 |
|
|
2025
Q1 | $307K | Hold |
6,947
| – | – | 0.01% | 1034 |
|
|
2024
Q4 | $251K | Hold |
6,947
| – | – | 0.01% | 1182 |
|
|
2024
Q3 | $223K | Hold |
6,947
| – | – | 0.01% | 1247 |
|
|
2024
Q2 | $262K | Hold |
6,947
| – | – | 0.01% | 1088 |
|
|
2024
Q1 | $342K | Hold |
6,947
| – | – | 0.01% | 969 |
|
|
2023
Q4 | $254K | Buy |
6,947
+1,158
| +20% | +$30.2K | 0.01% | 1122 |
|
|
2023
Q3 | $134K | Buy |
5,789
+977
| +20% | +$26.7K | 0.01% | 1451 |
|
|
2023
Q2 | $126K | Buy |
4,812
+2,178
| +83% | +$57.2K | ﹤0.01% | 1434 |
|
|
2023
Q1 | $67.8K | Hold |
2,634
| – | – | ﹤0.01% | 1788 |
|
|
2022
Q4 | $72.6K | Hold |
2,634
| – | – | ﹤0.01% | 1814 |
|
|
2022
Q3 | $75K | Hold |
2,634
| – | – | ﹤0.01% | 1703 |
|
|
2022
Q2 | $64K | Buy |
2,634
+345
| +15% | +$12.6K | ﹤0.01% | 1831 |
|
|
2022
Q1 | $129K | Hold |
2,289
| – | – | ﹤0.01% | 1469 |
|
|
2021
Q4 | $142K | Hold |
2,289
| – | – | ﹤0.01% | 1467 |
|
|
2021
Q3 | $145K | Hold |
2,289
| – | – | 0.01% | 1456 |
|
|
2021
Q2 | $189K | Buy |
2,289
+276
| +14% | +$21K | 0.01% | 1293 |
|
|
2021
Q1 | $148K | Hold |
2,013
| – | – | 0.01% | 1408 |
|
|
2020
Q4 | $146K | Buy |
2,013
+141
| +8% | +$9.08K | 0.01% | 1329 |
|
|
2020
Q3 | $89K | Hold |
1,872
| – | – | ﹤0.01% | 1501 |
|
|
2020
Q2 | $79K | Buy |
1,872
+975
| +109% | +$34.7K | ﹤0.01% | 1561 |
|
|
2020
Q1 | $24K | Hold |
897
| – | – | ﹤0.01% | 2078 |
|
|
2019
Q4 | $35K | Buy |
+897
| New | +$21K | ﹤0.01% | 2115 |
|
Other funds holding SWTX
Ameritas Investment Partners's SWTX Position: Q3 2025 in Review
Ameritas Investment Partners sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 7,428 shares — an estimated $349K sold.
Ameritas Investment Partners first reported a position in SWTX in Q4 2019 and held it in 23 quarters. The position peaked at $349K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Ameritas Investment Partners reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Ameritas Investment Partners sold 7,428 SpringWorks Therapeutics shares in Q3 2025, an estimated $349K.
- Ameritas Investment Partners first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 23 quarters.
- Ameritas Investment Partners's SpringWorks Therapeutics position peaked at $349K in Q2 2025.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Ameritas Investment Partners's 13F filing for Q3 2025, filed 10 Nov 2025.